ATXI: Avenue Therapeutics Inc. Company Sales Revenue

Corporate emblem and logo of Avenue Therapeutics, Inc. (ATXI)

Scientific interest in Avenue Therapeutics (ATXI) innovations in neuromedicine supports the share price, while the company's current sales demonstrate a clear cash flow trajectory. However, a shortage of rare components and disruptions in biomaterial logistics due to conflicts are hindering drug certification. The value of 0.00 indicates the current revenue level, which is subject to the influence of geopolitical pressure on international clinical trials.

ATXI: Avenue Therapeutics Inc Revenue and Sales Volume 07/04/2022 - 03/29/2025

Analytical breakdowns for Avenue Therapeutics

- market price and analyst price targets:
Summary company analysis:ATXI, avenuetx.com
Original product of Avenue Therapeutics Inc.

Avenue Therapeutics (ATXI) measures sales via aggregate cash flow from product realization, where daily market equilibrium tracking allows for an assessment of real liquidity and asset demand without time-based distortions. By analyzing the sales revenue of Avenue Therapeutics (ATXI), an investor determines the resilience of the business model of ATXI, whose specialization in hospital-based intensive pain therapy creates high switching costs and guarantees a stable commercial flow within closed inpatient circuits.

Analysis of competing companies

Company Sales Volume BIIB (Biogen)|Company Revenue Neurocrine Biosciences, Inc. (NBIX)|Company Revenue RGC (Regencell Bioscience Ltd)|Axsome Therapeutics, Inc. - Company Sales|ACAD (ACADIA Pharmaceuticals Inc) - Company Annual Revenue|Xenon Corp - Revenue and Sales Volume|Company Sales Revenue VKTX (Viking Therapeutics)|Supernus Pharmaceuticals (SUPN) - Company Revenue|Company Annual Revenue CPRX (Catalyst Pharmaceuticals, Inc.)|Company Revenue Denali Therapeutics Inc|Company Total Revenue Harmony Corp HRMY|Revenue and Sales Volume BHVN|Company Sales Amylyx Pharmaceuticals AMLX|Revenue and Sales Volume TRVI (Trevi Corp)|Company Gross Revenue Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Revenue and Sales Volume|CeriBell Corp (CBLL) - Company Sales|Prothena Corp (PRTA) - Company Revenue|Company Total Revenue Alector Inc. (ALEC)|Company Sales ANNX|omeros.com (OMER) - Company Gross Revenue|Company Revenue Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Company Sales Revenue|Revenue and Sales Volume VYGR (voyagertherapeutics.com)|Company Gross Revenue Neumora Therapeutics (NMRA)|SCLX - Company Revenue|Company Total Sales Volume Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Company Revenue|CGTX - Company Gross Revenue|IKT (inhibikase.com) - Revenue and Sales Volume|cassavasciences.com (SAVA) - Company Gross Revenue|Company Sales ASRT (Assertio Therapeutics)|Company Gross Revenue Coya Therapeutics|Vistagen - Company Sales|ovidrx.com (OVID) - Company Total Revenue|Acumen Pharmaceuticals - Revenue and Sales Volume|Company Total Revenue cervomed.com|ATHE: Revenue and Sales Volume|Clene Inc - Company Sales Revenue|Company Revenue PepGen|JUNS (Jupiter Neurosciences Inc) - Company Total Sales|Company Sales RLMD (Relmada Corp)|annovisbio.com - Company Sales Volume|Company Revenue gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Company Annual Revenue|KLTO - Company Revenue|Company Total Revenue NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Company Revenue|Company Sales Volume MTVA|Company Sales NRXS|Company Sales Helius Medical (HSDT)|Revenue and Sales Volume PASG|Neuphoria Therapeutics - Company Sales Volume|Company Revenue Minerva Neurosciences, Inc. NERV|Revenue and Sales Volume Athira Pharma ATHA|ADXN: Company Sales|Company Total Revenue Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Company Revenue|Company Total Revenue Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Revenue and Sales Volume|Company Sales Cortigent (CRGT)|Revenue and Sales Volume BCLI|Company Total Sales CARA|Company Revenue chromocell.com CHRO|Revenue and Sales Volume Eliem Therapeutics ELYM|ITCI: Company Sales|LBPH: Company Revenue|MRNS (Marinus Pharmaceuticals, Inc.) - Company Sales|NKGen - Company Sales Revenue|Company Revenue NeuroBo Pharmaceuticals, Inc.|Revenue and Sales Volume Sage Therapeutics Inc|Revenue and Sales Volume SNPX|TRVN - Company Total Revenue|Company Revenue vigilneuro.com VIGL|Company Gross Revenue Anew Medical (WENA)|cerevel.com - Revenue and Sales Volume